Non-specific rheumatic manifestations in patients with Hashimoto’s thyroiditis: a pilot cross-sectional study

[1]  G. Giuffrida,et al.  Autoimmune endocrine diseases. , 2018, Minerva endocrinologica.

[2]  A. Hubalewska-Dydejczyk,et al.  How much of the predisposition to Hashimoto’s thyroiditis can be explained based on previously reported associations? , 2018, Journal of Endocrinological Investigation.

[3]  S. Ioshii,et al.  Anti-parietal cell antibodies in patients with autoimmune thyroid diseases , 2018, Journal of Endocrinological Investigation.

[4]  L. Fu,et al.  Systemic lupus erythematosus and thyroid disease - Experience in a single medical center in Taiwan. , 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[5]  Y. Shoenfeld,et al.  Association between giant cell arteritis and thyroid dysfunction in a “real life” population , 2017, Endocrine.

[6]  A. Alibrandi,et al.  Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. , 2017, European journal of endocrinology.

[7]  A. Alibrandi,et al.  Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto’s thyroiditis , 2017, Endocrine.

[8]  M. Dougados,et al.  2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis , 2017, Annals of the rheumatic diseases.

[9]  E. Rosser,et al.  A clinical update on the significance of the gut microbiota in systemic autoimmunity. , 2016, Journal of autoimmunity.

[10]  N. Kamal,et al.  Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases , 2016, Medicine.

[11]  D. Comaneshter,et al.  Hypothyroidism among SLE patients: Case-control study. , 2016, Autoimmunity reviews.

[12]  A. Alibrandi,et al.  Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis. , 2016, Thyroid : official journal of the American Thyroid Association.

[13]  X. Mariette,et al.  Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations , 2016, Expert review of clinical immunology.

[14]  F. Trimarchi,et al.  Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto’s thyroiditis , 2016, Endocrine.

[15]  R. Ajjan,et al.  The Pathogenesis of Hashimoto’s Thyroiditis: Further Developments in our Understanding , 2015, Hormone and Metabolic Research.

[16]  C. Tagoe Rheumatic Symptoms in Autoimmune Thyroiditis , 2015, Current Rheumatology Reports.

[17]  S. Eroğlu,et al.  Assessment of thyroid disorders and autoimmunity in patients with rheumatic diseases. , 2014, Endocrine, metabolic & immune disorders drug targets.

[18]  N. Rose,et al.  Hashimoto thyroiditis: clinical and diagnostic criteria. , 2014, Autoimmunity reviews.

[19]  F. Salaffi,et al.  Psychometric characteristics of the Italian version of the revised Fibromyalgia Impact Questionnaire using classical test theory and Rasch analysis. , 2013, Clinical and experimental rheumatology.

[20]  C. Tagoe,et al.  Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients , 2013, Rheumatology International.

[21]  S. Chakravarty,et al.  Rheumatic manifestations of endocrine disease , 2013, Current opinion in rheumatology.

[22]  E. Badley,et al.  Comparison of health‐related outcomes for arthritis, chronic joint symptoms, and sporadic joint symptoms: A population‐based study , 2012, Arthritis care & research.

[23]  D. Cooper,et al.  The incidence and prevalence of thyroid autoimmunity , 2012, Endocrine.

[24]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[25]  A. Weetman Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum , 2011, Clinical endocrinology.

[26]  Roger Holder,et al.  Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. , 2010, The American journal of medicine.

[27]  J. Markenson Rheumatic manifestations of endocrine diseases , 2010, Current opinion in rheumatology.

[28]  R. Buchbinder,et al.  Quantifying the impact of transient joint symptoms, chronic joint symptoms, and arthritis: a population-based approach. , 2009, Arthritis and rheumatism.

[29]  G. Valesini,et al.  Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems , 2009, Arthritis research & therapy.

[30]  F. Salaffi,et al.  Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. , 2009, Clinical and experimental rheumatology.

[31]  F. Salaffi,et al.  Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect , 2009, Arthritis research & therapy.

[32]  Haiqing Zhang,et al.  Subclinical hypothyroidism , 2009 .

[33]  Y. Shoenfeld,et al.  The mosaic of autoimmunity: the role of environmental factors. , 2009, Frontiers in bioscience.

[34]  S. Guldıken,et al.  Frequency of rheumatic diseases in patients with autoimmune thyroid disease , 2007, Rheumatology International.

[35]  Dafna Gladman,et al.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.

[36]  L. Czirják,et al.  Association of systemic and thyroid autoimmune diseases , 2006, Clinical Rheumatology.

[37]  H. Moutsopoulos,et al.  Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases , 2004, Annals of the rheumatic diseases.

[38]  L. Punzi,et al.  Chronic autoimmune thyroiditis and rheumatic manifestations. , 2004, Joint, bone, spine : revue du rhumatisme.

[39]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[40]  L. Punzi,et al.  Clinical, laboratory and immunogenetic aspects of arthritis associated with chronic lymphocytic thyroiditis. , 1997, Clinical and experimental rheumatology.

[41]  L. Punzi,et al.  Thyroid gland disorders in primary Sjögren's syndrome. , 1996, Revue du rhumatisme.

[42]  T. Arima,et al.  Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases. , 1995, The Journal of clinical endocrinology and metabolism.

[43]  D. Alarcón-Segovia,et al.  Mixed connective tissue disease and overlap syndromes. , 1994, Clinics in dermatology.

[44]  Golding Dn Rheumatism and the thyroid. , 1993 .

[45]  K. Becker,et al.  The connective-tissue diseases and symptoms associated with Hashimoto's thyroiditis. , 1963, The New England journal of medicine.

[46]  P. Rosário Subclinical Hypothyroidism. , 2017, The New England journal of medicine.

[47]  W. Wiersinga,et al.  Autoimmune thyroid disease : old and new players , 2014 .

[48]  M. Mayes,et al.  An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .

[49]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[50]  J. Reveille,et al.  Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. , 2009, Clinical and experimental rheumatology.